Literature DB >> 16709950

Plasma fibronectin concentration: a risk factor for arterial thrombosis?

Deane F Mosher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16709950     DOI： 10.1161/01.ATV.0000223342.15969.7a

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  19 in total

1.  Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patients.

Authors:  Nadia N Casillas-Ituarte; Brian H Lower; Supaporn Lamlertthon; Vance G Fowler; Steven K Lower
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

2.  Polymer scaffold architecture is a key determinant in mast cell inflammatory and angiogenic responses.

Authors:  Daniel Abebayehu; Andrew J Spence; Michael J McClure; Tamara T Haque; Kevin O Rivera; John J Ryan
Journal:  J Biomed Mater Res A       Date:  2019-01-23       Impact factor: 4.396

3.  Structural and functional analysis of the tandem β-zipper interaction of a Streptococcal protein with human fibronectin.

Authors:  Nicole C Norris; Richard J Bingham; Gemma Harris; Adrian Speakman; Richard P O Jones; Andrew Leech; Johan P Turkenburg; Jennifer R Potts
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

Review 4.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

5.  Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Authors:  Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

6.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

7.  Increased serum fibronectin levels in patients with hemorrhagic fever with renal syndrome.

Authors:  Qunying Han; Wen Kang; Lei Zhang; Sai Lou; Qianzi Zhao; Zhengwen Liu
Journal:  Inflamm Res       Date:  2009-08-22       Impact factor: 4.575

Review 8.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

9.  Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.

Authors:  Shanna A Arnold; Holli A Loomans; Tatiana Ketova; Claudia D Andl; Peter E Clark; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2015-10-11       Impact factor: 5.150

10.  Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with "Corner Fractures".

Authors:  Chae Syng Lee; He Fu; Nissan Baratang; Justine Rousseau; Heena Kumra; V Reid Sutton; Marcello Niceta; Andrea Ciolfi; Guilherme Yamamoto; Débora Bertola; Carlo L Marcelis; Dorien Lugtenberg; Andrea Bartuli; Choel Kim; Julie Hoover-Fong; Nara Sobreira; Richard Pauli; Carlos Bacino; Deborah Krakow; Jillian Parboosingh; Patrick Yap; Ariana Kariminejad; Marie T McDonald; Mariana I Aracena; Ekkehart Lausch; Sheila Unger; Andrea Superti-Furga; James T Lu; Dan H Cohn; Marco Tartaglia; Brendan H Lee; Dieter P Reinhardt; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.